Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus

BACKGROUND: The Epstein-Barr virus (EBV) viral glycoprotein gp350 has been proposed as a candidate antigen for an EBV vaccine. However, the proposed formulations of these vaccines have not taken into account the presence of 2 unique EBV strains (EBV-1 and EBV-2) present in areas of high incidence of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Infect Dis
Egile Nagusiak: Smith, Nicholas A, Baresel, Paul C, Jackson, Conner L, Ogolla, Sidney, Toko, Eunice N, Heit, Sara, Piriou, Erwan, Sumba, Odada P, Middeldorp, Jaap M, Colborn, Kathryn L, Rochford, Rosemary
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Major Articles and Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6386812/
https://ncbi.nlm.nih.gov/pubmed/30312417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy601
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak